+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunosuppressive Drugs Market Research Reports

Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Ocular Graft versus host Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Ocular Graft versus host Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 60 Pages
  • Global
From
Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2024 - Product Thumbnail Image

Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Glucocorticoid receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Glucocorticoid receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2024 - Product Thumbnail Image

Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Heart Transplantation Therapeutics Market 2024-2028 - Product Thumbnail Image

Heart Transplantation Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 172 Pages
  • Global
From
Kidney Transplantation Therapeutics Market 2024-2028 - Product Thumbnail Image

Kidney Transplantation Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 171 Pages
  • Global
From
Global Immunomodulator Market - Product Thumbnail Image

Global Immunomodulator Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Global Graft Versus Host Disease (GvHD) Treatment Market - Product Thumbnail Image

Global Graft Versus Host Disease (GvHD) Treatment Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Methotrexate (CAS 59-05-2) Global Market Research Report 2024 - Product Thumbnail Image

Methotrexate (CAS 59-05-2) Global Market Research Report 2024

  • Report
  • October 2024
  • 50 Pages
  • Global
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
Loading Indicator

The Immunosuppressive Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that suppress the immune system. These drugs are used to treat autoimmune diseases, organ transplant rejection, and other conditions where the immune system is overactive. Immunosuppressive drugs work by blocking the action of certain cells in the immune system, preventing them from attacking healthy tissue. Immunosuppressive drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as steroids or chemotherapy. Common side effects of immunosuppressive drugs include nausea, vomiting, diarrhea, and increased risk of infection. Some of the major companies in the Immunosuppressive Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more